CME Group Inc. (NASDAQ:CME) shares hit a new 52-week high on Wednesday . The company traded as high as $128.16 and last traded at $128.12, with a volume of 644,683 shares trading hands. The stock had previously closed at $125.46.

CME has been the topic of a number of research reports. Deutsche Bank AG restated a “buy” rating and issued a $133.00 price objective (down previously from $134.00) on shares of CME Group in a report on Monday, May 15th. Jefferies Group LLC restated a “buy” rating and issued a $134.00 price objective (up previously from $128.00) on shares of CME Group in a report on Monday, July 17th. Royal Bank Of Canada set a $130.00 price objective on CME Group and gave the company a “buy” rating in a report on Monday, June 12th. BidaskClub lowered CME Group from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Finally, UBS AG restated a “buy” rating and issued a $135.00 price objective (up previously from $134.00) on shares of CME Group in a report on Wednesday. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and five have given a buy rating to the stock. CME Group presently has a consensus rating of “Hold” and a consensus target price of $131.75.

The company has a market capitalization of $42.74 billion, a price-to-earnings ratio of 25.67 and a beta of 0.72. The stock has a 50 day moving average price of $124.64 and a 200 day moving average price of $121.72.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.20 by $0.03. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The business had revenue of $925 million for the quarter, compared to the consensus estimate of $931.05 million. During the same period in the prior year, the business earned $1.14 earnings per share. The business’s revenue was up 2.1% on a year-over-year basis. On average, analysts anticipate that CME Group Inc. will post $4.81 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 25th. Stockholders of record on Friday, September 8th will be given a $0.66 dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $2.64 annualized dividend and a dividend yield of 2.10%. CME Group’s dividend payout ratio is currently 53.99%.

In related news, Director Martin J. Gepsman sold 200 shares of the stock in a transaction dated Wednesday, August 9th. The stock was sold at an average price of $126.14, for a total transaction of $25,228.00. Following the transaction, the director now directly owns 43,311 shares in the company, valued at $5,463,249.54. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, President Bryan T. Durkin sold 9,200 shares of the stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $125.13, for a total value of $1,151,196.00. Following the transaction, the president now owns 70,938 shares in the company, valued at $8,876,471.94. The disclosure for this sale can be found here. Insiders sold 68,134 shares of company stock worth $8,531,537 over the last 90 days. Company insiders own 0.57% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Fiduciary Trust Co. purchased a new position in CME Group during the second quarter worth about $105,000. Quadrant Capital Group LLC increased its stake in CME Group by 13.6% during the second quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock worth $111,000 after acquiring an additional 113 shares during the last quarter. Parallel Advisors LLC increased its stake in CME Group by 4.1% during the first quarter. Parallel Advisors LLC now owns 1,084 shares of the financial services provider’s stock worth $128,000 after acquiring an additional 43 shares during the last quarter. San Francisco Sentry Investment Group CA acquired a new stake in CME Group during the second quarter worth about $129,000. Finally, Whittier Trust Co. increased its stake in CME Group by 2.6% during the second quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock worth $133,000 after acquiring an additional 27 shares during the last quarter. Hedge funds and other institutional investors own 82.66% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The legal version of this report can be viewed at https://www.dailypolitical.com/2017/09/08/cme-group-inc-cme-reaches-new-1-year-high-at-128-16.html.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.